Need professional-grade analysis? Visit stockanalysis.com
$21.25B
28.53
1,315
N/A
Vimta Labs Limited (VIMTALABS) trades on NSE in INR. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at INR479.15, up 0.19% from the previous close.
Over the past year, VIMTALABS has traded between a low of INR380.70 and a high of INR877.20. The stock has lost 26.2% over this period. It is currently 45.4% below its 52-week high.
Vimta Labs Limited has a market capitalization of $21.25B, with a price-to-earnings ratio of 28.53.
Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; and a testing laboratory for water, alcoholic, and non-alcoholic beverages. In addition, the company offers environmental regulatory services, such as impact assessments and post project monitoring, to various industries, including power, infrastructure, cement, oil and gas, and mining, etc.; and EMI/EMC testing for electronic and electrical products/components. It provides solutions to agriculture, biologics and biosimilars, home and personal care, medical device, specialty chemicals, food, electrical and electronics, nutraceuticals, water and beverages, pharmaceuticals, crop care, environment, health and safety, and packaging industries. Vimta Labs Limited was founded in 1984 and is headquartered in Hyderabad, India.
Side-by-side comparison against top Healthcare peers.